Overall, the frequency distribution of somatic mutations detected in our cohort is comparable to large-scale studies of primary tumours [6] with VHL (40.5%), PBRM1 (40.5%), and KDM5C (32.9%) being the most frequently mutated genes in our cohort. This evidence concerns the gene PBRM1 and neoplasm.